Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

IL-33 supplementation fails to prevent trTreg reduction in established infection. by Santiago Boccardo (5927954)

Subjects:

List of genes associated with inflammatory response and skeletal muscle physiology. by Santiago Boccardo (5927954)

Subjects:

Tissue repair Tregs are reduced in target tissues and lymphoid organs during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Characterization of muscle and systemic tissue damage during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Early IL-33 administration increases trTregs and ILC2 numbers but does not enhance parasite-specific CD8+ T cells at 10 days post infection. by Santiago Boccardo (5927954)

Subjects:

Peripheral target tissues display inflammatory responses during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Early IL-33 administration effect on body weight, SM damage and total Tregs pool. by Santiago Boccardo (5927954)

Subjects:

Tregs frequency is reduced in lymphoid and non-lymphoid target tissues during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

IFN-γ limits trTreg expansion both <i>in vitro</i> after IL-33 stimulation and <i>in vivo</i> during <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Inflammatory and microbial-derived signals are unable to restrict IL-33 mediated expansion of trTregs <i>in vitro</i>. by Santiago Boccardo (5927954)

Subjects:

IL-33 supplementation fails to prevent trTreg reduction in established <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

ST2+ KLRG-1+ Tregs from <i>T</i>. <i>cruzi</i> infected mice exhibit a phenotype compatible with <i>bona fide</i> trTregs. by Santiago Boccardo (5927954)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”